Replies to post #15752 on ScripsAmerica Inc. (SCRCQ)

[Cats83]

Moderators please sticky this post.

[tutter18]

Excellent post Bsav! the PR today is the icing on the cake for me!!! Go Scripsamerica!! Tut

[Bsav88atty]

Just an fyi on the issue of prepaying notes. Regardless of whether the notes are paid 20 days before maturity or on the day of maturity, the company still pays the same premium. The company does not escape the premium simply by paying on the date of maturity. I'm 100% certain this is how these convertible notes are written. These noteholders write their paper to ensure they receive a ton of shares upon maturity or they receive a 30% or higher payoff. Quite simply, I'm in the wrong business!

And while I'm clarifying, I am also certain that today's news of the compounding pharmacy business is not a "corner pharmacy". Indeed, I believe the company was clear that "CP" stands for "Compounding Pharmacy" that makes pain creams.

Looking forward to March Madness!

[Alleyba1]

Alleyba says......

..........that post was one of the best I have ever read but subsequently to that news I believe was the acquisition by SCRC of the compounding pharmacy which further enhances your post and provides a tremendous amount of revenue going forward. And as we all know we are waiting for the final approval on the licenses to start the selling generic and controlled substances in 5 states which I would guess if you just took the TN. numbers you have to multiply those numbers by a minimum factor of 5. This to me is extremely conservative and is another big revenue stream.

Now Bsav when we add China and Hong Kong to the mix, eliminate convertibles going forward as you have pointed out there is no ceiling for this stock and the price of the stock here has to be an absolute steal. Your post was right on point. Finally, another revenue stream I missed is whether PIMD deal has been consummated and I am also of the opinion we will be positioned to expand internationally with Asia as the springboard to Latin America, in my opinion

[coolerheadsprevail]

Greetings my fellow SCRC shareholders (as well as those sitting on the sidelines waiting for a signal). Today the SCRC shareholders received more validating news:

1. No convertible notes since October 22;
2. No convertible notes will be written in the future; and
3. Scrips started prepaying the remaining notes!

This is the most exciting news the company has provided in a long time. Last week's news on Hong Kong's approval of RapiMed and the 62% increase in the joint venture revenues were validating and demonstrated the business is moving forward on different fronts. Despite this positive news, the drag on the share price continued as the noteholders and Ironridge aggressively battled each other to drive the price down. Today, however, Scrips took a significant step toward removing the drag and easing the non-stop selling pressure. By squelching many concerns over the company's convertible debt structure, management lifted much of the overhang that has kept a lid on the share price.

Many have questioned whether Scrips was still writing the convertible notes. The company answered in the negative: "I can assure our shareholders that the company has not taken on any additional convertible debt since October 22nd of last year." This is fantastic news...no fluff or sales puffery! And equally or more important, Bob Schneiderman said, "moving forward we will not add any more of this type of debt to our balance sheet as we are experiencing growth in our existing areas of business and expect increased revenues based on new ventures and products." Wow! This news further validates the company is the real deal -- a very rare penny stock.

The above was from a PR SCRC issued w/great fanfare on 2/19/14, which was touted all the way to high heaven by JOSEPH ZAMPETTI and his core of fellow Section 17(b)-violating "investor relations related consultants". This post actually cracked me up when it was first posted, and it still cracks me up today. It reads like a PR itself rather than a post. But I digress...

I don't see any distinctions that Bob is even pretending to make between "horrendous" convert notes and "not-so-horrendous-and-kinda-bordering-on-warm,-fuzzy,-and-downright-friendly" convert notes. Do you? It seems very very clear that he is conveying in no uncertain terms that AS A CATEGORY, convert notes are a thing of the past.

The funny thing is that this PR was issued on 2/19/14, only 40 days before the conclusion of Q1'14. And in the 10Q, SCRC disclosed that during Q1'14, it inked "several" new convert notes. Just let that sink in for a minute. I'll wait...

...What this means is that Bob either (1) Flat out lied in the 2/19/14 PR and actually began inking new convert notes before this PR was issued, or (2) DECEIVED AND MISLED investors with this PR, because he knew exactly what he was attempting to convey with this PR -- just like he knew that the PR's back in late-OCT'13 re: sending a team to China to sign RapiMeds sales deals would cause the market to believe the launch was not only imminent but also massive, EVEN THOUGH HE PRIVATELY KNEW THAT HE HAD NOT EVEN SUBMITTED THE APPLICATION TO THE REGULATORY AGENCIES IN CHINA YET -- and with only 40 days left before the end of Q1, this means that he issued this PR knowing full well that he intended to break this promise and ink more convert notes anyways in the VERY near future following 2/19/14.